MARROSU, MARIA GIOVANNA
 Distribuzione geografica
Continente #
EU - Europa 411.350
NA - Nord America 24.250
AS - Asia 9.044
SA - Sud America 1.181
AF - Africa 194
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 22
Totale 446.066
Nazione #
IT - Italia 405.398
US - Stati Uniti d'America 23.921
SG - Singapore 3.530
CN - Cina 3.451
UA - Ucraina 1.823
SE - Svezia 1.113
BR - Brasile 931
FI - Finlandia 702
DE - Germania 670
GB - Regno Unito 663
VN - Vietnam 652
FR - Francia 501
HK - Hong Kong 306
IN - India 209
CA - Canada 195
KR - Corea 176
BD - Bangladesh 131
NL - Olanda 97
AR - Argentina 78
IQ - Iraq 75
RU - Federazione Russa 71
TR - Turchia 65
PK - Pakistan 61
JP - Giappone 59
MX - Messico 57
ZA - Sudafrica 49
EC - Ecuador 46
ES - Italia 46
MA - Marocco 43
PL - Polonia 43
BE - Belgio 42
AT - Austria 38
VE - Venezuela 37
ID - Indonesia 35
SA - Arabia Saudita 34
UZ - Uzbekistan 34
CO - Colombia 31
PH - Filippine 27
CL - Cile 25
IL - Israele 24
AU - Australia 21
EU - Europa 21
MY - Malesia 21
CZ - Repubblica Ceca 19
AZ - Azerbaigian 18
IR - Iran 18
JM - Giamaica 18
JO - Giordania 17
DZ - Algeria 16
KE - Kenya 16
LT - Lituania 16
TH - Thailandia 14
TN - Tunisia 14
CH - Svizzera 12
EG - Egitto 12
RO - Romania 11
UY - Uruguay 11
AE - Emirati Arabi Uniti 10
ET - Etiopia 10
IE - Irlanda 10
AL - Albania 9
CR - Costa Rica 9
MU - Mauritius 9
NP - Nepal 9
OM - Oman 9
PY - Paraguay 9
PS - Palestinian Territory 8
TW - Taiwan 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
HR - Croazia 7
LB - Libano 7
BG - Bulgaria 6
CU - Cuba 6
DK - Danimarca 6
GT - Guatemala 6
KG - Kirghizistan 6
KZ - Kazakistan 6
PA - Panama 6
GR - Grecia 5
HN - Honduras 5
HU - Ungheria 5
NG - Nigeria 5
PE - Perù 5
RS - Serbia 5
SN - Senegal 5
SV - El Salvador 5
GA - Gabon 4
GE - Georgia 4
NO - Norvegia 4
PR - Porto Rico 4
PT - Portogallo 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
EE - Estonia 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 446.018
Città #
Cagliari 398.047
Uta 5.912
Fairfield 2.551
Woodbridge 2.154
Ashburn 2.048
Singapore 1.714
Chandler 1.537
Houston 1.415
San Jose 1.265
Wilmington 1.129
Ann Arbor 1.047
Seattle 999
Boardman 962
Jacksonville 895
Dallas 888
Cambridge 855
Nyköping 710
Beijing 625
Helsinki 402
Dearborn 392
Nanjing 355
Los Angeles 329
Lauterbourg 279
Hong Kong 274
New York 261
Santa Clara 258
Boston 247
The Dalles 246
Hefei 240
Shanghai 207
Ho Chi Minh City 205
Buffalo 190
Milan 173
Seoul 167
Hanoi 140
San Diego 135
Council Bluffs 132
Shenyang 131
Munich 125
Guangzhou 108
Nanchang 106
Toronto 102
Hebei 90
Redwood City 87
Changsha 86
Jiaxing 86
São Paulo 85
Norwalk 84
London 81
Verona 81
Washington 75
Tianjin 68
Chicago 66
Orem 64
Sassari 64
Atlanta 62
Redondo Beach 60
Rome 48
Jinan 45
Mountain View 45
Zhengzhou 45
Hangzhou 44
Brooklyn 43
Tokyo 43
Phoenix 41
Dong Ket 40
Frankfurt am Main 39
Columbus 37
Ningbo 37
Warsaw 37
Da Nang 34
Montreal 33
Stockholm 32
Auburn Hills 31
Brussels 31
Tashkent 31
Orange 30
Johannesburg 29
Taizhou 29
Chennai 28
Kunming 28
Pune 28
Rio de Janeiro 28
Haiphong 27
San Francisco 25
Amsterdam 24
Baghdad 24
Istanbul 24
Nuremberg 24
Florence 22
Belo Horizonte 21
Manchester 21
Porto Alegre 21
Curitiba 20
Wuhan 20
Baku 18
Denver 18
Dhaka 18
Falls Church 18
Miami 18
Totale 432.395
Nome #
Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation 6.162
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 5.983
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles 5.248
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 4.945
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 4.585
EFFECTS OF SIX MONTHS TRAINING ON PHYSICAL CAPACITY AND METABOREFLEX ACTIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS. 4.501
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.491
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia 4.404
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 4.307
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 4.287
The burden of multiple sclerosis variants in continental Italians and Sardinians 4.223
Quantitative assessment of the effects of 6 months of adapted physical activity on gait in people with multiple sclerosis: a randomized controlled trial 4.218
Overexpression of the cytokine BAFF and autoimmunity risk 4.130
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 4.046
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 4.024
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.937
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.894
Clinical Assessment of Gait in Individuals with Multiple Sclerosis Using Wearable Inertial Sensors: Comparison with Patient-Based Measure 3.846
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.843
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.825
Effectiveness and Limitations of Unsupervised Home-Based Balance Rehabilitation with Nintendo Wii in People with Multiple Sclerosis 3.806
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.732
The Required Coefficient of Friction for evaluating gait alterations in people with Multiple Sclerosis during gait 3.713
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 3.670
Walking improvements with nabiximols in patients with multiple sclerosis 3.653
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.621
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.613
Factors influencing MS outcome in Sardinia: a clinical and genetic study 3.592
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.592
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 3.444
Dynamical insights into the differential characteristics of Mycobacterium avium subsp. paratuberculosis peptide binding to HLA-DRB1 proteins associated with multiple sclerosis 3.422
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.414
Impact of the media on future hope in multiple sclerosis 3.392
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.320
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.314
Are static and functional balance abilities related in individuals with Multiple Sclerosis? 3.297
Cardiac involvement in patients with lamin A/C gene mutations: a cohort observation 3.242
Oral agents in multiple sclerosis 3.215
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 3.212
Influence of treatments in multiple sclerosis disability: a cohort study 3.185
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.122
Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis 3.107
Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity 3.099
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 3.064
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 3.051
Refining the connection between gait and cognition: training the body to improve the brain 2.989
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis 2.982
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.980
Relationship between gait initiation and disability in individuals affected by multiple sclerosis 2.965
Effect of 6 months of adapted physical activity on gait patterns in individuals with multiple sclerosis: a three-dimensional quantitative analysis 2.955
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population 2.881
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.877
Effect of spasticity on kinematics of gait and muscular activation in people with multiple sclerosis 2.819
Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study 2.729
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.676
Postural adaptation during a Nintendo Wii balance training 2.675
Perception of risk and shared decision making process in multiple sclerosis 2.657
Smoothness of gait detects early alterations of walking in persons with multiple sclerosis without disability 2.643
Cardiac and muscle imaging findings in a family with X-linked Emery-Dreifuss muscular dystrophy 2.616
Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia 2.573
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.561
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 2.538
Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients 2.535
Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel 2.503
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.452
Genetic loci linked to type 1 diabetes and multiple sclerosis families in Sardinia 2.441
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patient 2.412
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.341
The cohort of the multiple sclerosis center of Cagliari 2.336
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 2.333
Balance patterns in people with multiple sclerosis using Nintendo Wii 2.319
Muscle elastography: a new imaging technique for multiple sclerosis spasticity measurement 2.312
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.309
Evolution of the phenotype in a family with an LMNA gene mutation presenting with isolated cardiac involvement 2.306
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.294
Induction and escalation therapies in multiple sclerosis 2.288
Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-α2-chain gene: a chance association or a novel phenotype? 2.276
Presence of oligoclonal IgG bands in Sardinians with multiple sclerosis is influenced by carriage of different HLA DRB1-DQB1 haplotypes 2.261
Cognitive screening in patients with amyotrophic lateral sclerosis in early stages 2.248
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 2.238
Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations 2.105
Multiple sclerosis and fertilization in vitro with embryo transfer (FIVET): a case report 2.075
Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: Importance of G2019S and R1441C mutations in sporadic Parkinson’s disease patients 2.063
Medulloblastoma induces unusual headache with clinical picture of basilar-type migraine complicated by ischaemic infarcts 2.061
Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population 2.057
Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population 2.056
Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin 2.038
Novel Characterization of Gait Impairments in People with Multiple Sclerosis by Means of the Gait Profile Score 2.028
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy 2.019
The co-inheritance of type 1 diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone 1.994
Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis 1.980
The Italian multiple sclerosis register 1.936
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks 1.934
Lack of evidence for a role of the myelin basic protein gene in multiple sclerosis susceptibility in Sardinian patients 1.923
Genetic and clinical characteristics of skeletal and cardiac muscle in patients with lamin A/C gene mutations 1.918
Heat shock protein 27 R127W mutation: evidence of a continuum between axonal Charcot-Marie-Tooth and distal hereditary motor neuropathy 1.899
Bipolar affective disorder preceding frontotemporal dementia in a patient with C9ORF72 mutation: is there a genetic link between these two disorders? 1.894
Parkin exon rearrangements and sequence variants in LRRK2 mutations carriers: analysis on a possible modifier effects on LRRK2 penetrance 1.889
The risk of bipolar disorders in multiple sclerosis 1.885
Vagal nerve stimulation effects on cerebellar tremor in multiple sclerosis 1.876
Totale 302.741
Categoria #
all - tutte 568.752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 568.752


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.549 0 0 0 0 0 0 0 0 0 0 0 3.549
2021/202218.941 2.535 1.435 848 1.601 1.589 1.125 849 946 1.793 1.920 2.294 2.006
2022/202324.683 2.330 3.509 3.302 1.960 1.903 2.566 1.003 2.214 1.458 1.531 1.769 1.138
2023/202425.151 1.707 1.364 903 1.878 2.593 3.911 2.672 2.203 1.249 2.130 2.435 2.106
2024/202566.681 22.110 21.004 7.604 4.023 2.627 2.703 3.648 377 672 643 588 682
2025/202615.692 1.024 696 1.762 1.355 1.167 1.243 2.705 1.193 1.182 1.617 1.013 735
Totale 446.807